MIV Therapeutics Inc. is an advanced stage, research and development company pursuing the commercialization of the next generation of fully biocompatible coatings for stents and other medical devices with the intent of providing healing solutions for cardiovascular disease and other conditions. In collaboration with the University of British Columbia (UBC), the Company has developed unique coating technologies that utilize Hydroxyapatite (HAp) for application on medical devices and drug delivery systems.MIVT has a strategic alliance with the University of British Columbia (UBC), where it has licensed from the university worldwide rights to technologies for coating stents and other medical devices with HAp. This coating enhances the biocompatibility of implanted devices since it is a material that is found in the body as the main constituent of bone.MIVT’s technology is considered to be suitable for broad applications in cardiovascular and non-vascular drug/device combination products. The Company’s goal is to continue on its path of success and diversify its portfolio to capitalize on these potential applications, accessing the $200 billion market of combination drug/device products.
MIV Therapeutics Inc. is Vancouver-based company (British Columbia, Canada) with a phone number 6043019545. Our data show that the company is located at the address: 1 8765 Ash Street. The company has a web site: www.mivtherapeutics.com.
Unfortunately сompany staff has not yet provided of company's activities, mission and detailed description.